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Background: In large epidemiological studies it is often challenging to obtain biological samples. Self-sampling by
study participants using dried blood spots (DBS) technique has been suggested to overcome this challenge. DBS is
a type of biosampling where blood samples are obtained by a finger-prick lancet, blotted and dried on filter paper.
However, the feasibility and efficacy of collecting DBS samples from study participants in large-scale epidemiological
studies is not known. The aim of the present study was to test the feasibility and response rate of collecting self-sampled
DBS and saliva samples in a population–based study of women above 50 years of age.
Methods: We determined response proportions, number of phone calls to the study center with questions about
sampling, and quality of the DBS. We recruited women through a study conducted within the Norwegian Breast Cancer
Screening Program. Invitations, instructions and materials were sent to 4,597 women. The data collection took place over
a 3 month period in the spring of 2009.
Results: Response proportions for the collection of DBS and saliva samples were 71.0% (3,263) and 70.9% (3,258),
respectively. We received 312 phone calls (7% of the 4,597 women) with questions regarding sampling. Of the 3,263
individuals that returned DBS cards, 3,038 (93.1%) had been packaged and shipped according to instructions. A total of
3,032 DBS samples were sufficient for at least one biomarker analysis (i.e. 92.9% of DBS samples received by the
laboratory). 2,418 (74.1%) of the DBS cards received by the laboratory were filled with blood according to the
instructions (i.e. 10 completely filled spots with up to 7 punches per spot for up to 70 separate analyses). To
assess the quality of the samples, we selected and measured two biomarkers (carotenoids and vitamin D). The
biomarker levels were consistent with previous reports.
Conclusion: Collecting self-sampled DBS and saliva samples through the postal services provides a low cost,
effective and feasible alternative in epidemiological studies.
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A common challenge for large epidemiological studies is
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lenge is especially true for blood samples. Trained
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need to visit the participants. Furthermore, blood sam-
ples typically must be shipped directly from the medical
center to the receiving laboratory overnight in order to
ensure the stability of the biomarkers. To overcome
some of these challenges it has been suggested that par-
ticipants could self-sample dried blood spots (DBS) for
blood analysis and saliva samples for DNA analysis, and
ship such specimens by postal service directly to the
laboratory.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Study population overview.
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obtained by a finger-prick lancet are blotted on filter
paper [1]. The DBS sample should be dried before being
sent by regular mail, and transferred to −80°C for long
term storage at the receiving laboratory. Most biomarkers
are stable in DBSs for months or years at ambient or re-
frigerator temperatures, and for even longer periods at
−80°C. The DBS platform is especially advantageous in
studies of infants and small children since it is minimally
invasive and small volumes often are available [2,3].
The feasibility of collecting such DBS samples from
study participants in large-scale epidemiological studies
is not known. Although the DBS analysis platform is
routinely used for DNA, protein, virus, drugs and blood
sampling in clinical practice [4-7], only a few studies
have reported on the feasibility of postal collection of
DBSs in population-based studies [8-10]. The expected
response proportion is not known in large epidemio-
logical studies. Specifically, it is not clear whether partic-
ipants would be reluctant to take their own blood
samples. It is also not known whether participants would
be able to understand written instructions for obtaining
and shipment of the blood sample adequately, and to
what extent participants would contact study personnel
with questions about the DBS protocol.
The aim of this study was to measure the feasibility of
collecting self-collected DBS and saliva samples in a
population-based study, where participants would be
asked to ship the samples by standard postal service.
Feasibility was measured by response proportion, the
number of phone calls, number of adequate blood spots
submitted and the quality of the blood samples.
To determine the quality of mailed DBS samples, we
analyzed two key biomarkers, carotenoids and vitamin
D (25-hydroxy-D3), in a subset of samples. Blood carot-
enoids may serve as biomarkers for fruit and vegetable
intake [11-13]. They are lipid-soluble plant pigments
with antioxidant activities [14]. Lutein, zeaxanthin, β-
kryptoxanthin, α-carotene, β-carotene, and lycopene
are among the most studied carotenoids due to their
abundance in food and plasma. Vitamin D is a fat-soluble
secosteroid. Sun exposure plays a central role in vitamin D
metabolism, as it is formed in the skin under the influence
of UV light [15-17]. Both carotenoids and vitamin D are
important biomarkers in epidemiological studies of nutri-
ents and disease.
Methods
Subjects and Study Design
The present study was part of a larger project on diet
and breast cancer in Norway [18]. The main aims of the
large project were to gain insight into the effects of
women’s diet, genetics and hormones on the breast tis-
sue, as monitored through mammographic density.In 2006 and 2007, the Norwegian Breast Cancer Screen-
ing Program included a question in their standard ques-
tionnaire sent with the invitation letter for the
mammographic screening appointment on whether the
woman was willing to complete a dietary questionnaire,
and receive blood and saliva sampling kits. A food fre-
quency questionnaire (FFQ) was mailed to a random sam-
ple of 10,000 women who agreed. Out of them, 6,974
returned the dietary questionnaire. Blood and saliva sample
collection kits were mailed to a random sample of 4,597 of
those women who had returned the questionnaire, in the
spring of 2009. This study was conducted over a period of
about 3 months. The inclusion and characteristics of the
study participants are shown in Figure 1 and Table 1.
The blood sampling kit consisted of two blood DBS
cards (Protein SaverTM 903R Cards, Whatman, Sanford,
USA), two lancets, one 5-mg desiccant pouch (Reàl
Marine A/S Stavanger, Norway), one aluminum zip-lock
bag (Whatman, Sanford, USA), Cutisoft® wipes, Mesoft
swabs (Mölnlycke Healthcare) and one small bandage.
The airtight aluminum bag was used to protect the
blood sample during shipment. The desiccant bag was
included to remove any moisture from the DBS cards.
To suppress the degradation of carotenoids in the DBS
samples [1], the first two circles in the DBS cards were
impregnated with a proprietary stabilizing solution sup-
plied by Vitas AS, Oslo, Norway. The saliva sampling kit
consisted of a saliva collection tube and a bag, Oragene™
DNA Self-Collection Kit (DNA Genotek Inc., Kanata,
ON, Canada). The bag protected the saliva sample dur-
ing mailing. Detailed instructions for blood and saliva
sample collection were mailed together with the sample
collection kits (Additional file 1).
Blood Samples
Validity of blood samples
Upon receipt, the DBS cards were assessed by a trained
research assistant for both validity and amount of blood
Table 1 Characteristics of the study participants
Overall (N = 4597) Adequate/valid blood samples Inadequate blood samples or did not return
blood samples
(N = 3038/66%)1 (N = 1559/34%)
Variables N Mean (SD)2 N % Mean (SD)2 N % Mean (SD)2
Age (years) 4573 57 (4.7) 3014 57 (4.1) 1559 57 (5.1)
50-54 1499 953 32 546 35
55-59 1528 1012 34 516 33
60-64 1409 963 32 446 29
65-69 137 86 3 51 3
Chi-square p-value5 0.045
Body mass index (kg/m2)4 4243 25 (4.6) 2714 25 (4.4) 1529 25 (4.9)
<25 1562 1244 46 318 21
>25 < 29 1680 1082 40 598 39
>29 1001 388 14 613 40
Chi-square p-value5 <0.001
Education (in years) 4542 3013 1529
<=10 830 512 17 318 21
11-14 1830 1232 41 598 39
15+ 1882 1269 42 613 40
Chi-square p-value5 0.007
Physical activity (less strenuous)3 3661 2414 1247
Hours per week
0 86 47 2 39 3
1 422 275 11 147 12
2 to 3 1620 1082 45 538 43
4 to 5 917 605 25 312 25
6+ 616 405 17 211 17
Chi-square p-value5 0.24
Physical activity (strenuous) 3557 2353 1204
Hours per week
0 1521 986 42 535 44
1 859 571 24 288 24
2 to 3 929 638 27 291 24
4 to 5 180 116 5 64 5
6+ 68 42 2 26 2
Chi-square p-value5 0.32
Smoking 3649 2397 1252
Never 1583 1096 46 487 39
Current 778 431 18 347 28
Past 1288 870 36 418 33
Chi-square p-value5 <0.001
1Adequate/valid samples were samples returned in an aluminium bag with a desiccant pouch while invalid samples were samples without a dessicant pouch or
aluminium bag.
2Unadjusted mean and standard deviation.
3Physical activity: less strenuous = walking, bicycling, working in the garden more strenuous = aerobic, running, bicycling at high intensity.
4excluded women with height <125, and weight < 30 kg >170 kg.
5Compared the adequate (n = 3038) with the inadequate blood samples (n = 1559).
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Table 2 Number of participants submitting adequately
filled spots and blood spots allowing at least one punch
for analysis
Number of
blood
spots
Number of participants
with adequately filled
blood spots
Number of participants
with blood spots allowing
at least one punch1
10 2,418 2,655
≥9 2,521 2,729
≥8 2,613 2,796
≥7 2,692 2,850
≥6 2,750 2,896
≥5 2,834 2,964
≥4 2,871 2,988
≥3 2,906 3,011
≥2 2,938 3,026
≥1 2,960 3,032
1a punch is 3.2 mm in diameter and would provide 3.1 μl of blood.
Figure 2 Response proportions in study where DBS cards were
shipped to 4597 women who had returned a dietary questionnaire.
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they were shipped in aluminum bags with the desiccant
pouch. The amount of blood received was assessed by the
number and size of the blood spots. Samples were classi-
fied into three categories: (a) filled, (b) small and (c) empty
blood spots (a spot is the area within the circle, 13 mm in
diameter that is supposed to be filled with blood). In a
“filled blood spot” the spot was completely or almost com-
pletely filled with blood. Such a spot contained approxi-
mately 50 μl of blood and was enough for about 7
punches. A punch is 3.2 mm in diameter and would pro-
vide 3.1 μl of blood [19]. A “small blood spot” was defined
as a blood spot sufficient for only one punch. An “empty
blood spot” was defined as a blood spot with less blood
than 3.2 mm in diameter or completely empty. The DBS
cards with blood were stored in the laboratory at −80°C.
Analysis of blood samples
A subset of 381 valid samples was selected for analysis
of vitamin D and carotenoids (lutein, zeaxanthin, β-
kryptoxanthin, α-carotene, β-carotene and lycopene).
The 381 samples were selected based on the following
inclusion criteria: age at screening >50 years, energy in-
take >2100 kJ and <15000 kJ and body mass index >
15 kg/m2 and <50 kg/m2.
High-performance liquid chromatography with ultraviolet
detection and liquid chromatography-mass spectrometry
were used for analysis of carotenoids and vitamin D, re-
spectively [20,21].
Hematocrit values in normal adult women are about
50%. In order to compare DBS results with results from
analysis of plasma, all DBS values were multiplied with a
factor of 2 [2].
Statistics
We used excel to calculate unadjusted chisquare tests
for the overall differences in proportions (test for
homogeneity). All tests of significance were 2-sided and
p < 0.05 was considered statistically significant. The
IBM Statistical Package for Social Sciences (SPSS) was
used for calculating frequencies in Table 2 [Version 20
(IBM Corp 2012) Armonk, NY:IBM Corp].
Ethics statement
The present study was conducted according to the Declar-
ation of Helsinki guidelines and approved by The Regional
Committee for Medical Research Ethics. All the partici-
pants gave their written informed consent.
Results
Of the 4,597 sampling kits sent to participants, we re-
ceived DBS samples from 3,263 women (71.0%) (Figure 2)
and saliva samples from 3,258 women (70.9%). A total of
117 (2.5%) of the 4,597 mailed kits were returned due to
Figure 4 Written comments from 300 out of 3,263 participants.
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process.
We received 312 (6.8%) phone calls from the 4,597
participants. Reasons for the phone calls included the
following: participants that refused (n = 90) or were un-
available to participate of other reasons (n = 13), partici-
pants needing a second DBS card (n = 84) or other
equipment (n = 25), sickness and medications (n = 31),
participants not able to get blood after finger-prick (n = 9)
and additional questions or reasons (n = 60) (Figure 3).
Of the 3,263 women who submitted the DBS samples, a
total of 300 participants (9.2%) wrote comments on the
form included with the sampling kit (Figure 4). Most of
these comments were regarding lack of blood (n = 189)
and difficulty in performing the finger-prick test (n = 42).
Some comments were also about broken lancets (n = 30),
insufficient number of lancets (n = 30). Only a small
number reported feeling unwell when performing the
finger-prick test (n = 9).
Out of 3,263 received DBS samples, 3038 (93.1%) were
packed and shipped as instructed, while 225 participants
(Figure 2) either omitted the desiccant pouches or failed
to place the DBS cards in the aluminum bags as
instructed. Because this could affect the stability of the
biomarkers, we classified these as inadequate or invalid
blood samples. There were a number of differences be-
tween the 3038 women with adequate samples and the
1559 women who did not return a sample or who
returned an inadequate sample (Table 1). Those with
valid samples tended to be slimmer, more highly educated
and less likely to be current smokers.
Additionally, a few participants (n = 6) submitted DBS
cards that only contained empty spots or spots with lessFigure 3 Phone calls from 312 out of the 4,597 participants.blood than required for a single punch. Out of 3,263
DBS cards submitted to the laboratory, 3,032 (92.9%)
could be used for at least one biomarker analysis
(Table 2). Table 2 also presents the number of partici-
pants that were able to submit DBS cards with 1–10 ad-
equately filled blood spots (with each spot enabling up
to 7 punches for individual analysis) and 1–10 blood
spots which allow at least one punch for analysis. Thus,
2,418 (74.1%) DBS cards were returned with all 10 spots
filled with blood according to the instructions. These
DBS cards will allow up to 70 punches for separate ana-
lyses from each participant.
Measurements of carotenoids and vitamin D in a sub-
set of 381 samples are shown in Table 3, where we also
list results obtained in previous studies from Norway or
Nordic countries [20,22-25]. The results demonstrate
that plasma values are similar to those obtained in previ-
ous studies. One exception was lycopene, which was
somewhat lower in this study than in the other studies,
but higher than in the study from Finland.
Discussion
In the present study, we found that by sending out DBS
and saliva sample collection kits with instructions to
women aged 50–69 who had agreed to participate in a
dietary study, self-collected samples were received from
about 70% of the participants. The collection resulted in
phone calls from about 7% of women, where about a
third was related to the lancets, or difficulties in using
them. Of the blood samples received, about 93% were
considered valid and could be used for at least one bio-
marker analysis. Overall 74% had 10 filled spots that
would we used for up to 70 separate blood analyses.
Table 3 The mean concentration of carotenoids and 25-hydroxy vitamin D3 from DBS samples compared with plasma from other studies in theNordic
countries
Lutein
(μmol/L)
Zeaxanthin
(μmol/L)
β-kryptoxanthin
(μmol/L)
α-carotene
(μmol/L)
β-carotene
(μmol/L)
Lycopene
(μmol/L)
25-hydroxy D3
(nmol/L)
N (Carotenoids -
vitamin D=
References
(Carotenoids –
vitamin D)
Norway – DBS samples
present study mean (SD)1
0.23 (±0.13) 0.046 (±0.02) 0.16 (±0.11) 0.13 (±0.10) 0.43 (±0.29) 0.25 (±0.12) 43 (±12) 403 - 403 The present
study
Norway previous study
mean (SD)
0.17 (±0.07) 0.04 (±0.02) 0.16 (±0.11) 0.14 (±0.12) 0.50 (±0.32) 0.63 (±0.33) n.a 346 – n.a. [20]
Denmark study mean (SD) 0.34 (±0.14) 0.07 (±0.04) 0.23 (±0.21) 0.22 (±0.18) 0.47 (±0.38) 0.53 (±0.29) 75 (±29) 98 – 2,016 [22,23]
Sweden study mean (SD) 0.28 (±0.12) 0.06 (±0.04) 0.20 (±0.19) 0.20 (±0.22) 0.54 (±0.73) 0.52 (±0.27) 69 (±23) 97 – 116 [22,23]
Finland study mean (SD) 0.20 (±0.10) 0.04 (±0,02) 0.20 (±0.18) 0.19 (±0.13) 0.69 (±0.47) 0.09 (±0.06) 38.1 (±4.6) 620 – 1,283 [25,28]
Values are means and SD (standard derivation).
n.a. = not analyzed.
1In order to compare DBS results with results from analysis of plasma, all DBS values were multiplied with a factor of 2.
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results to those obtained in other studies.
The participation rate in this study of self-sampling
was good. The fact that response proportion was similar
for the DBS samples and saliva samples, suggests that
those who are willing to provide a biological sample are
also willing to do so, even if it entails a finger prick.
However, women who provided DBS and saliva samples
had agreed to participate in the study and had also com-
pleted a dietary questionnaire. One could argue that the
relatively high proportion that responded represented a
highly motivated group. Further, women with an ad-
equate/valid sample were more highly educated and
healthier than those who did not participate or had an
invalid sample. The largest difference was found for
smoking, confirming the participants represented a se-
lected group. A case–control study from the US that in-
cluded a $ 2.00 bill to encourage participation, yielded
similar participation (68%), and found that the participa-
tion with DBS was better than venipuncture (62%) [8].
Their study was, however smaller, with 134 female can-
cer cases and 256 controls. In the present study we did
not include a cash incentive, but still obtained a partici-
pation rate of 70% among those who had already
returned a dietary questionnaire.
We also determined the usefulness or quality of DBS
cards returned to the laboratory. Based on our assess-
ments, about 93% of the received DBS cards had suffi-
cient blood spots for at least one biomarker analysis and
most of these had 10 adequate spots.
Only about 7% of the participants contacted the study
center by phone. Although a third of these were refusals,
about a third were regarding lack of or malfunctioning
equipment (lancets). The study staff tested out a series
of lancets in advance, both internally and in a pilot, be-
fore deciding on the one that was the most reliable.
Since several participants still complained about the lan-
cet, any future study should test in more detail several
lancets before commencing a large epidemiological
study, or consider including two lancets.
The levels of the biomarkers (vitamin D and caroten-
oids) analyzed in this study were compared with findings
from other studies to confirm the reliability of DBS to
plasma analysis of biomarkers. The concentrations of
these biomarkers in human blood vary across Europe
[22,23]. We compared our results with those in similar
population samples (women, comparable age) from stud-
ies in Nordic countries [23-28]. Levels of all biomarkers
analyzed in the present study, were similar with those
from other studies. The levels of lycopene in the present
study were somewhat lower than three other studies but
higher than a study from Finland. These variations prob-
ably reflect different dietary intake of tomato products
like tomato sauce, pizza and ketchup [29] in thedifferent populations, since these foods are the major
sources for lycopene.
Some caution must be taken when comparing DBS
data with plasma analyses performed in blood samples
taken by venipuncture. Absolute values from DBS sam-
ples (i.e. whole blood) are expected to be about 50% of
values reported in plasma [2], because whole blood in-
cludes blood cells as well as plasma. In normal adult
women, hematocrit values are about 50%, and thus
about half of the blood volume represents blood cells.
Thus, in the comparison between DBS and plasma ana-
lysis, all DBS values were multiplied with a factor of 2.
In addition, the recovery or extraction of biomarkers
from DBS might also differ in comparison to plasma.
Thus, development of separate reference ranges of differ-
ent biomarkers in DBS cards is needed.
Unlike venipuncture, trained personnel were not re-
quired for DBS collection and the transportation and
storage of samples was easier. The reduced storage space
requirements are also a major advantage, especially
when thousands of samples are to be collected in large
epidemiological studies. The volume needed for storage
of DBS samples is typically less than one tenth of similar
aliquots of plasma samples. Furthermore, obtaining
small samples for analysis is often also much simpler
from DBS cards, since no thawing and refreezing of plasma
samples are needed.
A major advantage of the DBS cards is reduced cost, a
typical limiting factor when performing epidemiological
studies. A direct comparison between the cost when
using self-sampled DBS cards and plasma samples from
venipuncture by health personnel is difficult, but will in
most instances be very large (e.g. reduced costs for
transportation of participants to study or blood collection
center, for equipment, storage and personnel).
There are a number of advantages of sample collection
by postal service. It may increase participation rate in a
population-based study requiring blood samples. In par-
ticular, this sample collection technique increases the
possibility of obtaining samples from people living in re-
mote rural areas. Further, the rapidness of the data col-
lection, collecting samples from over 3000 women in
less than 3 months, is a strong advantage. There are also
some limitations with self-sampled DBS collection via
the postal service. One of the disadvantages is that the
participants must follow the instructions carefully and
failure to do so may affect the results. In our study, we
observed that 7% did not return the samples packaged
as we had instructed with the desiccant and inside the
aluminum bag.
Conclusion
We explored the feasibility of self-sampled DBS cards
and saliva samples shipped by postal service. Response
Sakhi et al. BMC Cancer  (2015) 15:265 Page 8 of 9proportions were 70.9% and 71.0%, respectively. Of the
DBS samples obtained, over 90% were considered valid
and sufficient for at least one biomarker analysis. The
data collection resulted in a limited number of phone
calls to the study center. Our study suggests that the
DBS collection method is efficient, yields a high re-
sponse proportion and blood spots that can be used in
large population-based studies. Overall self-sampled
DBS and saliva samples shipped through the postal ser-
vice appears to offer a low cost, effective and feasible
means for collecting biological samples in epidemio-
logical studies.
Additional file
Additional file 1: Dried blood sample (DBS) collection instructions.
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